MedTrace Logo

Photobiomodulation and Root Resorption

NCT04044989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-08-05

No results posted yet for this study

Summary

Objectives: The aim of this study is to investigate the effect of photobiomodulation therapies on root resorption compared with the placebo group. Materials and Methods: 30 patients, who were admitted to the …………. University Faculty of Dentistry Orthodontics Department for treatment, with an indication of upper right 1st premolar tooth extraction was included. Before the individuals' orthodontic treatment, 0.022 slot MBT brackets and tubes were placed on the maxillary 1st premolar and molar. A 150g buccal tipping force was applied to the 1st premolar. Individuals were then randomly divided into 3 groups. For the first group; laser application was performed with a 810 nm GaAlAs laser device at 0,3,7,14,21 and 28 days to 8 J/cm2. Second group; an LED application according to the manufacturer's instructions with a 850 nm wavelength and 20 mW/cm2 output power for 10 minutes per day during the experiment. Third group; a placebo therapy was completed whereby a laser device that did not make active pulses was used. At the end of four weeks, the amount of root surface resorption was compared using micro-CT imaging after the extraction of the teeth.

Conditions

  • Orthodontic Pathological Resorption of External Root
  • Orthodontic Appliance Complication
  • Orthodontic Tooth Movement

Interventions

DEVICE

Laser

Diode laser device was used for photobiomodulation

DEVICE

light-emitting diode (LED)

LED device was used for photobiomodulation

DEVICE

Placebo

Diode laser device was used for placebo effect

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Aysegul Gulec, PhD · Gaziantep University Orthodontics Department

  • Merve Goymen, PhD · Gaziantep University Orthodontics Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2018-06-05
Completion
2018-12-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04044989 on ClinicalTrials.gov